A Lesson from the Green Pass Experience in Italy: A Narrative Review
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. The Scientific Viability of the Italian Green Pass as Incentive-Based Model
3.2. The Green Pass and Its Detractors: Concerns and Criticisms
3.3. Proposed Recommendations and Alternatives
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Lambert, H.; Gupte, J.; Fletcher, H.; Hammond, L.; Lowe, N.; Pelling, M.; Raina, N.; Shahid, T.; Shanks, K. COVID-19 as a global challenge: Towards an inclusive and sustainable future. Lancet Planet. Health 2020, 4, e312–e314. [Google Scholar] [CrossRef]
- WHO. Coronavirus Disease (COVID-19) Pandemic. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&gclid=EAIaIQobChMIo56C4sz19wIVFM53Ch2k7AIHEAAYAyAAEgLZH_D_BwE (accessed on 23 May 2022).
- Nicola, M.; Alsafi, Z.; Sohrabi, C.; Kerwan, A.; Al-Jabir, A.; Iosifidis, C.; Agha, M.; Agha, R. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int. J. Surg. 2020, 78, 185–193. [Google Scholar] [CrossRef] [PubMed]
- WHO. Regional Office for Europe. Coronavirus Disease (COVID-19) Pandemic. Available online: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov (accessed on 23 May 2022).
- Hale, T.; Anania, J.; de Mello, B.A.; Angrist, N.; Roy Barnes, R.; Boby, T.; Blake, E.C.; Cavalieri, A.; Di Folco, M.; Edwards, B.; et al. Variation in Government Responses to COVID-19 Version 13.0. Blavatnik School of Government Working Paper. 11 March 2022. Available online: www.bsg.ox.ac.uk/covidtracker (accessed on 23 May 2022).
- García-Montero, C.; Fraile-Martínez, O.; Bravo, C.; Torres-Carranza, D.; Sanchez-Trujillo, L.; Gómez-Lahoz, A.M.; Guijarro, L.G.; García-Honduvilla, N.; Asúnsolo, A.; Bujan, J.; et al. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines 2021, 9, 433. [Google Scholar] [CrossRef] [PubMed]
- El-Elimat, T.; AbuAlSamen, M.M.; Almomani, B.A.; Al-Sawalha, N.A.; Alali, F.Q. Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan. PLoS ONE 2021, 16, e0250555. [Google Scholar] [CrossRef]
- Haas, E.J.; Angulo, F.J.; McLaughlin, J.M.; Anis, E.; Singer, S.R.; Khan, F.; Brooks, N.; Smaja, M.; Mircus, G.; Pan, K.; et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data. Lancet 2021, 397, 1819–1829. [Google Scholar] [CrossRef]
- Bernal, J.L.; Andrews, N.; Gower, C.; Gallagher, E.; Simmons, R.; Thelwall, S.; Stowe, J.; Tessier, E.; Groves, N.; Dabrera, G.; et al. Effectiveness of COVID-19 vaccines against the B. 1.617. 2 (Delta) variant. N. Engl. J. Med. 2021, 385, 585–594. [Google Scholar] [CrossRef]
- Ali, I.; Ali, S.; Iqbal, S. COVID-19 vaccination: Concerns about its accessibility, affordability, and acceptability. Front. Med. 2021, 8, 647294. [Google Scholar] [CrossRef]
- Sorell, T.; Butler, J. The politics of covid vaccine hesitancy and opposition. Political Q. 2022, 93, 347–351. [Google Scholar] [CrossRef]
- World Health Organization. Ten Threats to Global Health in 2019. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed on 30 June 2022).
- Aw, J.; Seng, J.J.B.; Seah, S.S.Y.; Low, L.L. COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries. Vaccines 2021, 9, 900. [Google Scholar] [CrossRef]
- Shmueli, L. The role of incentives in deciding to receive the available COVID-19 vaccine in Israel. Vaccines 2022, 10, 77. [Google Scholar] [CrossRef]
- Montanari Vergallo, G.; Der Rio, A.; Negro, F.; Zaami, S. COVID-19 vaccine mandate: What are the current European public perspective? Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 643–652. [Google Scholar] [PubMed]
- Phelan, A.L. COVID-19 Immunity Passports and Vaccination Certificate: Scientific, Equitable, and Legal Challenges. Lancet 2020, 395, 1595–1598. [Google Scholar] [CrossRef]
- Alemanno, A.; Bialasiewicz, L. Certifying Health: The Unequal Legal Geographies of COVID-19 Certificates. Eur. J. Risk Regul. 2021, 12, 273–286. [Google Scholar] [CrossRef]
- Hall, M.A.; Studdert, D.M. “Vaccine Passport” Certification—Policy and Ethical Considerations. N. Engl. J. Med. 2021, 385, e32. [Google Scholar] [CrossRef] [PubMed]
- Lang, I.G. EU COVID-19 Certificates: A Critical Analysis. Eur. J. Risk Regul. 2021, 12, 298–307. [Google Scholar] [CrossRef]
- Regulation 2021/953 of the European Parliament and of the Council of 14 June 2021 on a Framework for the Issuance, Verification and Acceptance of Interoperable COVID-19 Vaccination, Test and Recovery Certificates (EU Digital COVID Certificate) to Facilitate Free Movement during the COVID-19 Pandemic, 15 June 2021, L 211/1. Available online: https://eur-lex.europa.eu/eli/reg/2021/953/oj (accessed on 15 June 2022).
- DECRETO-LEGGE 23 Luglio 2021, n. 105 Misure Urgenti per Fronteggiare l’emergenza Epidemiologica da COVID-19 e Per l’esercizio in Sicurezza di Attività Sociali ed Economiche. (21G00117) (GU Serie Generale n.175 del 23-07-2021). Available online: https://www.gazzettaufficiale.it/eli/id/2021/07/23/21G00117/sg (accessed on 10 June 2022).
- Palmieri, S.; Goffin, T. De Jure and De Facto: An Overview on the Italian Measure on Compulsory Vaccination. Eur. J. Health Law 2022, 29, 151–164. [Google Scholar] [CrossRef]
- Waitzberg, R.; Triki, N.; Alroy-Preis, S.; Lotan, T.; Shiran, L.; Ash, N. The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries. Int. J. Environ. Res. Public Health 2021, 18, 11212. [Google Scholar] [CrossRef]
- Kosciejew, M.R.H. COVID-19 immunity (or vaccine) passports: A documentary overview and analysis of regimes of health verification within the coronavirus pandemic. J. Doc. 2022, 78, 463–484. [Google Scholar] [CrossRef]
- Porat, T.; Burnell, R.; Calvo, R.A.; Ford, E.; Paudyal, P.; Baxter, W.L.; Parush, A. “Vaccine Passports” May Backfire: Findings from a Cross-Sectional Study in the UK and Israel on Willingness to Get Vaccinated against COVID-19. Vaccines 2021, 9, 902. [Google Scholar] [CrossRef]
- Drury, J.; Mao, G.; John, A.; Kamal, A.; Rubin, G.J.; Stott, C.; Vandrevala, T.; Theresa, M.; Marteau, T.M. Behavioural responses to COVID-19 health certification: A rapid review. BMC Public Health 2021, 21, 1205. [Google Scholar] [CrossRef]
- Gostin, L.O.; Cohen, I.G.; Shaw, J. Digital Health Passes in the Age of COVID-19: Are “Vaccine Passports” Lawful and Ethical? JAMA 2021, 325, 1933–1934. [Google Scholar] [CrossRef] [PubMed]
- Montanari Vergallo, G.; Zaami, S.; Negro, F.; Brunetti, P.; Del Rio, A.; Marinelli, E. Does the EU COVID Digital Certificate Strike a Reasonable Balance between Mobility Needs and Public Health? Medicina 2021, 57, 1077. [Google Scholar] [CrossRef] [PubMed]
- Reno, C.; Sanmarchi, F.; Stoto, M.A.; Fantini, M.P.; Lenzi, J. The impact of health policies and vaccine rollout on the COVID-19 pandemic waves in Italy. Health Policy Technol. 2022, 11, 100604. [Google Scholar] [CrossRef] [PubMed]
- Stefanizzi, P.; Bianchi, F.P.; Brescia, N.; Ferorelli, D.; Tafuri, S. Vaccination strategies between compulsion and incentives. The Italian Green Pass experience. Expert Rev. Vaccines 2022, 21, 423–425. [Google Scholar] [CrossRef]
- Spitale, G.; Biller-Andorno, N.; Germani, F. Concerns Around Opposition to the Green Pass in Italy: Social Listening Analysis by Using a Mixed Methods Approach. J. Med. Internet Res. 2022, 24, e34385. [Google Scholar] [CrossRef]
- Moccia, G.; Carpinelli, L.; Savarese, G.; De Caro, F. Vaccine Hesitancy and the Green Digital Pass: A Study on Adherence to the Italian COVID-19 Vaccination Campaign. Int. J. Environ. Res. Public Health 2022, 19, 2970. [Google Scholar] [CrossRef] [PubMed]
- Gallè, F.; Sabella, E.A.; Roma, P.; Da Molin, G.; Diella, G.; Montagna, M.T.; Ferracuti, S.; Liguori, G.; Orsi, G.B.; Napoli, C. Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy. Vaccines 2021, 9, 1222. [Google Scholar] [CrossRef]
- Mills, M.C.; Rȕttenauer, T. The effect of mandatory COVID-19 certificates on vaccine uptake: Synthetic-control modelling of six countries. Lancet Public Health 2022, 7, e15–e22. [Google Scholar] [CrossRef]
- Oliu-Barton, M.; Pradelski, B.S.R.; Woloszko, N.; Guetta-Jeanrenaud, L.; Aghion, P.; Artus, P.; Fontanet, A.; Martin, P.; Wolff, G.B. The effect of COVID certificates on vaccine uptake, health outcomes, and the economy. Nat. Commun. 2022, 13, 3942. [Google Scholar] [CrossRef]
- Gometz, G. Green pass e discriminazione. Un’analisi. L’Ircocervo 2021, 20, 157–171. [Google Scholar]
- Ferraro, F. Passaporto vaccinale e discriminazione: Stigma sociale e disuguaglianza giustificata. Not Polit. 2022, 38, 38–57. [Google Scholar]
- Mori, M. Sul significato etico e filosofico del “Green Pass” o “Passaporto Vaccinale”: Un contributo alla riflessione. Sci. Filos. 2021, 25, 67–81. [Google Scholar]
- DECRETO-LEGGE 26 Novembre 2021, n. 172 Misure Urgenti per il Contenimento Dell’epidemia da COVID-19 e Per lo Svolgi Mento in Sicurezza Delle Attività Economiche e Sociali. (21G00211). (GU Serie Generale n.282 del 26-11-2021). Available online: https://www.gazzettaufficiale.it/eli/id/2021/11/26/21G00211/sg (accessed on 30 June 2022).
- Saban, M.; Myers, V.; Shetrit, S.B.; Wilf-Miron, R. Issues surrounding incentives and penalties for COVID-19 vaccination: The Israeli experience. Prev. Med. 2021, 153, 106763. [Google Scholar] [CrossRef] [PubMed]
- Burke, T. Complexity and causation. Sound. Interdiscip. J. 2007, 90, 33–47. [Google Scholar] [CrossRef]
- Tambone, V.; Ghilardi, G. Aware and cooperative reduction. Clin. Ter. 2012, 163, e133–e143. [Google Scholar] [PubMed]
- Kamin-Friedman, S.; Peled Raz, M. Lessons from Israel’s COVID-19 Green Pass program. Isr. J. Health Policy Res. 2021, 10, 61. [Google Scholar] [CrossRef] [PubMed]
- Luster, T.; Albin, E.; Gross, A.; Tabenkin, M.; Davidovitch, N. Promoting Vaccination from a Human Rights and Equity Perspective: Lessons from the Israeli “Green Pass”. Eur. J. Risk Regul. 2021, 12, 308–320. [Google Scholar] [CrossRef]
- Henderson, J.; Ward, P.R.; Tonkin, E.; Meyer, S.B.; Pillen, H.; McCullum, D.; Toson, B.; Webb, T.; Coveney, J.; Wilson, A. Developing and Maintaining Public Trust During and Post-COVID-19: Can We Apply a Model Developed for Responding to Food Scares? Front. Public Health 2020, 8, 369. [Google Scholar] [CrossRef]
- Ward, P.R. Improving access to, use of, and outcomes from public health programs: The importance of building and maintaining trust with patients/clients. Front. Public Health 2017, 5, 22. [Google Scholar] [CrossRef]
- Campanozzi, L.L.; Guglielmelli, E.; Cella, E.; Ghilardi, G.; Michilli, M.; Molina, A.; Ciccozzi, M.; Tambone, V. Building Trust in Social Robotic. A pilot survey. IEEE Technol. Soc. Mag. 2019, 2, 45–54. Available online: https://ieeexplore.ieee.org/document/8924732 (accessed on 20 July 2022). [CrossRef]
- Ghilardi, G.; Campanozzi, L.L.; Ciccozzi, M.; Ricci, G.; Tambone, V. The political nature of medicine. Lancet 2020, 395, 1340–1341. Available online: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930168-9 (accessed on 20 July 2022). [CrossRef]
Reference Article | Aim of the Study | Key Points about Green Pass | Proposed Recommendations |
---|---|---|---|
Montanari Vergallo et al. COVID-19 vaccine mandates: what are the current European public perspectives? [15]. | To elaborate on the European policy choices for the prevention of SARS-CoV-2 contagion, with a close focus on the rules and regulations enacted in Italy so far. |
|
|
Pamieri et al. De Jure and De Facto: An Overview on the Italian Measure in Compulsory Vaccination [22]. | To trace the most important profiles of the vaccination obligation implemented de jure and de facto by the Italian government. |
| |
Reno et al. The impact of health policies and vaccine rollout on the COVID-19 pandemic waves in Italy [29]. | To describe the impact of vaccine rollout and health policies on the evolution of the COVID-19 pandemic in Italy from March 2020 to October 2021 using a set of epidemiological indicators. |
|
|
Stefanizzi et al. Vaccination strategies between compulsion and incentives. The Italian Green Pass Experience [30]. | Editorial about the Italian Green Pass experience. |
|
|
Spitale et al. Concerns Around Opposition to the Green Pass in Italy: Social Listening Analysis by Using a Mixed Methods Approach [31]. | To understand and describe the concerns of individuals opposed to the Green Pass in Italy, the main arguments of their discussions, and their characterization. |
|
|
Moccia et al. Vaccine Hesitancy and the Green Digital Pass: A Study on Adherence to the Italian COVID-19 Vaccination Campaign [32]. | To investigate the phenomenon of vaccination hesitancy and the underlying reasons, as well as any changes to the membership following the obligation of the Green Pass. |
|
|
Gallè et al. Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy [33]. | To assess, through an online questionnaire, the acceptance of COVID-19 vaccination in a sample of older adults from southern Italy during the national vaccination campaign. |
|
|
Mills et al. The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic -control modelling of six countries [34]. | To investigate the effect of certification on vaccine uptake by designing a synthetic control model comparing 6 countries (Denmark, Israel, Italy, France, Germany, and Switzerland) that introduced certification (April–August, 2021), with 19 control countries. |
|
|
Oliu-Barton et al. The effect of COVID certificates on vaccine uptake, health outcomes, and the economy [35]. | To estimate the effect of COVID-19 certificates on vaccine uptake for France, Germany, and Italy using counterfactuals constructed via innovation diffusion theory. |
|
|
Gometz. Green pass e discriminazione [36]. | To analyse green pass certification criticism and the related conceptual and normative assumptions in order to provide an opportunity for reflection on the notion of discrimination and its criteria and conditions of employment. |
|
|
Ferraro. Passaporto vaccinale e discriminazione: stigma sociale e disuguaglianza giustificata [37]. | To address accusations of state discrimination against those who are not vaccinated by choice or for health reasons related to the introduction of the COVID-19 vaccine certification in Italy. |
|
|
Mori. Sul significato etico e filosofico del “Green Pass” o “Passaporto Vaccinale”: Un contributo alla riflessione [38]. | To contribute to the current debate on the COVID-19 pandemic and its consequenc-es. |
|
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Campanozzi, L.L.; Tambone, V.; Ciccozzi, M. A Lesson from the Green Pass Experience in Italy: A Narrative Review. Vaccines 2022, 10, 1483. https://doi.org/10.3390/vaccines10091483
Campanozzi LL, Tambone V, Ciccozzi M. A Lesson from the Green Pass Experience in Italy: A Narrative Review. Vaccines. 2022; 10(9):1483. https://doi.org/10.3390/vaccines10091483
Chicago/Turabian StyleCampanozzi, Laura Leondina, Vittoradolfo Tambone, and Massimo Ciccozzi. 2022. "A Lesson from the Green Pass Experience in Italy: A Narrative Review" Vaccines 10, no. 9: 1483. https://doi.org/10.3390/vaccines10091483